A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors

por Zhu, Zhongling, Qian, Zhengzi, Yan, Zhao, Zhao, Cuicui, Wang, Huaqing, Ying, Guoguang
Publicado 2013

Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma

por Qian, Zhengzi, Song, Zheng, Zhang, Huilai, Wang, Xianhuo, Zhao, Jing, Wang, Huaqing
Publicado 2015

Genetic polymorphism and transcriptional regulation of CREBBP gene in patient with diffuse large B-cell lymphoma

por Zhao, Haifeng, Kan, Yutian, Wang, Xinyuan, Chen, Leiyuan, Ge, Peng, Qian, Zhengzi
Publicado 2019

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy

por Zhao, Peiqi, Qiu, Lihua, Zhou, Shiyong, Li, Lanfang, Qian, Zhengzi, Zhang, Huilai
Publicado 2021

A Phase I Trial to Evaluate the Multiple-Dose Safety and Antitumor Activity of Ursolic Acid Liposomes in Subjects with Advanced Solid Tumors

por Qian, Zhengzi, Wang, Xianhuo, Song, Zheng, Zhang, Huilai, Zhou, Shiyong, Zhao, Jing, Wang, Huaqing
Publicado 2015

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

por Zhao, Peiqi, Zhu, Lei, Li, Lanfang, Zhou, Shiyong, Qiu, Lihua, Qian, Zhengzi, Xu, Wengui, Zhang, Huilai
Publicado 2021

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma

por Liu, Meijing, Deng, Haobin, Mu, Juan, Li, Qing, Pu, Yedi, Jiang, Yili, Deng, Qi, Qian, Zhengzi
Publicado 2021

Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy

por Zhao, Peiqi, Xu, Yuanlin, Ji, Wei, Li, Lanfang, Qiu, Lihua, Zhou, Shiyong, Qian, Zhengzi, Zhang, Huilai
Publicado 2022

Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer

por Zhao, Peiqi, Xu, Yuanlin, Ji, Wei, Zhou, Shiyong, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Wang, Xianhuo, Zhang, Huilai
Publicado 2021

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma

por Wu, Zizheng, Guan, Qingpei, Han, Xue, Liu, Xianming, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Wang, Xianhuo, Zhang, Huilai
Publicado 2021

Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes

por Wang, Xiaoxuan, Li, Guanghao, Zhang, Yidan, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Wang, Xianhuo, Li, Qiang, Zhang, Huilai
Publicado 2022

A retrospective analysis of EBV‐DNA status with the prognosis of lymphoma

por Qiu, Lihua, Si, Junqi, Kang, Junnan, Chen, Zehui, Nuermaimaiti, Rexidan, Qian, Zhengzi, Li, Lanfang, Zhou, Shiyong, You, Mingjian James, Zhang, Huilai, Tian, Chen
Publicado 2022

Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

por Qu, Zhenjie, Zhang, Tingting, Gao, Fenghua, Gong, Wenchen, Cui, Yaoli, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Meng, Bin, Ren, Xiubao, Li, Lanfang, Wang, Xianhuo, Zhang, Huilai
Publicado 2022

Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients

por Fei, Yue, Yu, Jingwei, Li, Yang, Li, Linyu, Zhou, Shiyong, Zhang, Tingting, Li, Lanfang, Qiu, Lihua, Meng, Bin, Pan, Yi, Ren, Xiubao, Qian, Zhengzi, Wang, Xianhuo, Zhang, Huilai
Publicado 2020

Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL

por Zhang, Tingting, Liu, Hengqi, Jiao, Lei, Zhang, Zhenzhen, He, Jin, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Gong, Wenchen, Meng, Bin, Ren, Xiubao, Zhang, Huilai, Wang, Xianhuo
Publicado 2022

PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma

por Zhang, Huilai, Lu, Yaxiao, Zhang, Tingting, Guan, Qingpei, Wang, Xiaoxuan, Guo, Yixian, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Gong, Wenchen, Meng, Bin, Ren, Xiubao, Wang, Xianhuo
Publicado 2022

m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment

por Zhang, Tingting, Liu, Hengqi, Gao, Fenghua, Gong, Wenchen, Cui, Yaoli, He, Jin, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Meng, Bin, Ren, Xiubao, Zhang, Huilai, Wang, Xianhuo
Publicado 2022

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China

por Gao, Fenghua, Zhang, Tingting, Liu, Xia, Qu, Zhenjie, Liu, Xianming, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Gong, Wenchen, Meng, Bin, Ren, Xiubao, Wang, Xianhuo, Zhang, Huilai
Publicado 2022

Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma

por Li, Yang, Fei, Yue, Liu, Lu, Song, Zheng, Meng, Xiangrui, Qiu, Lihua, Li, Lanfang, Qian, Zhengzi, Zhou, Shiyong, Ren, Xiubao, Bi, Chengfeng, Meng, Bin, Zhang, Huilai, Wang, Xianhuo, Fu, Kai
Publicado 2021

Bortezomib enhances the anti-cancer effect of the novel Bruton’s tyrosine kinase inhibitor (BGB-3111) in mantle cell lymphoma expressing BTK

por Wang, Xianhuo, Fei, Yue, Liu, Xia, Zhang, Tingting, Li, Wei, Jia, Xiaohui, Liu, Xianming, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Ren, Xiubao, Zhai, Qiongli, Meng, Bin, Li, Lanfang, Zhang, Huilai
Publicado 2021